SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-09-158299
Filing Date
2009-07-29
Accepted
2009-07-29 17:25:02
Documents
4
Period of Report
2009-07-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 20678
2 PRESS RELEASE, DATED JULY 29, 2009 dex991.htm EX-99.1 86388
3 PRESS RELEASE, DATED JULY 27, 2009 dex992.htm EX-99.2 5093
4 GRAPHIC g29141ex99_1001a.jpg GRAPHIC 4979
  Complete submission text file 0001193125-09-158299.txt   121028
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51531 | Film No.: 09971176
SIC: 2834 Pharmaceutical Preparations